Home Health‎NAFDAC Destroys ₦22.73bn Worth of Substandard Products‎

‎NAFDAC Destroys ₦22.73bn Worth of Substandard Products‎

by Torkuma Gbor
0 comments

The National Agency for Food and Drug Administration and Control (NAFDAC) says it has destroyed unwholesome products valued at ₦22.73 billion between January and August 2026.

‎‎The agency’s Resident Media Consultant, Olusayo Akintola, disclosed this in a statement issued in Abuja on Sunday, describing the exercise as a major achievement in strengthening Nigeria’s regulatory system.

‎‎Akintola said the achievement was among the agency’s 2026 performance highlights presented at the International Pharmaceutical Regulators Programme (IPRP) Management Committee Meeting held in Prague, Czech Republic, from November 18 to 19.

‎He explained that the scorecard covered progress in regulatory system strengthening, digital innovation, pharmaceutical manufacturing, enforcement and international collaboration.

banner

‎‎According to him, NAFDAC carried out 5,542 enforcement operations within the eight-month period, conducted 213 raids, seized 821 products, shut down 179 premises, made 52 arrests and imposed 221 sanctions.

‎‎He identified the agency’s continued retention of the World Health Organisation (WHO) Maturity Level 3 status and its ongoing efforts to attain Maturity Level 4, the highest rating under the WHO Global Benchmarking Tool, as another major achievement.

‎‎Akintola said NAFDAC had introduced several digital initiatives to support the transition, including the Integrated Regulatory Information Management System (IRIMS), Performance Management System (i-PMS) and Good Manufacturing Practice Inspection (GMPi).

‎‎Other initiatives, he said, included the Application and AI-assisted Technical-Screening Tools (TST) and the revised Med-Safety App, designed to improve the reporting of substandard and falsified medical products as well as adverse drug reactions.

‎On local pharmaceutical production, Akintola said the agency had recorded considerable progress through its 5+5 Policy, with more than 70 per cent of finished pharmaceutical products and 36 products now manufactured locally.

‎‎He explained that the policy was designed to reduce Nigeria’s dependence on imported medicines and improve the country’s medicine security.

‎‎The media consultant also highlighted NAFDAC’s growing regulatory influence across Africa, noting that the agency had emerged as a reference National Regulatory Authority.

‎‎He said the agency had hosted regulatory authorities from Uganda, The Gambia, Mozambique and Côte d’Ivoire for technical capacity development and institutional benchmarking.

‎‎Akintola further disclosed that Nigeria ratified the African Medicines Agency (AMA) Treaty and deposited its instruments of ratification on October 25.

‎‎He attributed the achievements to the strategic vision and leadership of NAFDAC’s Director-General, Prof. Mojisola Adeyeye.

‎‎According to the statement, Adeyeye’s administration has continued to promote institutional reforms, science-based regulation, digital innovation and international regulatory cooperation.

‎‎“NAFDAC continues to strengthen its regulatory capacity; enhance public health protection; and position Nigeria as a leading regulatory authority in Africa,” the statement added.

‎‎(NAN)

You may also like

Leave a Comment